本页面由Tiger Trade Technology Pte. Ltd.提供服务

Carisma Therapeutics, Inc.

0.0342
+0.00309.62%
成交量:11.06万
成交额:3,548.89
市值:143.11万
市盈率:0.18
高:0.0345
开:0.0310
低:0.0310
收:0.0312
52周最高:1.27
52周最低:0.0300
股本:4,184.51万
流通股本:3,125.58万
量比:1.04
换手率:0.35%
股息:- -
股息率:- -
每股收益(TTM):0.1920
每股收益(LYR):-1.4588
净资产收益率:-362.79%
总资产收益率:33.03%
市净率:-1.65
市盈率(LYR):-0.02

数据加载中...

2025/09/18

重要事件披露

Form 8-K - Current report
2025/08/29

重要事件披露

Form 8-K - Current report
2025/08/29

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/08/08

重要事件披露

Form 8-K - Current report
2025/08/08

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/15

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/07/15

重要事件披露

Form 8-K - Current report
2025/06/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/23

重要事件披露

Form 8-K - Current report
2025/06/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/12

重要事件披露

Form 8-K - Current report
2025/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/30

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/16

重要事件披露

Form 8-K - Current report
2025/03/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/31

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/13

重要事件披露

Form 8-K - Current report